Skip to main content

ProShare Advisors LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in CRNX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$637,636
-$47,213 QoQ
Shares Held
17,040
-9.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 264 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. CRNX ranks #42 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $637,636 17,040
2026-03-31 $684,849 18,856
2025-12-31 $964,562 20,721
2025-09-30 $783,186 18,804
2025-06-30 $633,870 22,040
2025-03-31 $806,234 24,038
2024-12-31 $1,487,320 29,089
2024-09-30 $993,077 19,434
2024-06-30 $613,802 13,704
2024-03-31 $783,178 16,731
2023-12-31 $536,404 15,076
2023-09-30 $356,017 11,971
2023-06-30 $187,966 10,431
2022-12-31 $205,362 11,222
2022-09-30 $202,468 10,309
2022-06-30 $187,973 10,079
2022-03-31 $297,620 13,559
2021-12-31 $476,009 16,755
2021-09-30 $274,365 13,034
2021-06-30 $305,690 16,217
2021-03-31 $180,090 11,786
2020-12-31 $156,268 11,075